The investigator has informed us that he has submitted an abstract for the ASH annual meeting in December 2014 in which he has analyzed certain safety and efficacy data from MF patients in the MF Pilot Study and updated his analysis from the preliminary data he presented in December 2013. In accordance with ASH policies, abstracts submitted to the ASH annual meeting are embargoed from the time of submission. To be eligible for presentation at the ASH annual meeting, information contained in the abstract, as well as additional data and information to be presented at the annual meeting, may not be made public before the abstract has been published/presented in connection with the ASH annual meeting. We have not reviewed or independently analyzed the data selected by the investigator for inclusion in the abstract. Our analyses may result in conclusions that are materially different from the investigator's analyses and therefore additional or updated data should be considered carefully and with caution. Please refer to the risk factor entitled, "Risks Related to Our Business-Success in early clinical trials may not be indicative of results in subsequent clinical trials. Likewise, data reported by investigators from time-to-time is subject to review and verification procedures that could result in material differences to final data and may change as more patient data becomes available." in Part II, Item 1A entitled, "Risk Factors", in this Form 10-Q.
As stock sold off from 10.12 late in the day, a big buyer of around 2000 jan 11 calls at .25 to 42 cents came in. These were all on the offer which was just sitting there at a quarter most of the day. Offer went to 80 cents right before close and then backed off. Very strange trading as you would expect stock to trade higher during this volume. Looks like a big up day very soon...IMHO
Amount beneficially owned:
Percent of class
They doubled their holdings since last filing. Follow the money
BLACKROCK FUND ADVISORS 09/30/2014 5,663,201
This is very good results; CR's and PR's. There is no drug that does this. And spleen reduction. But a short cabal has control of stock, just like the Washington Post said the other day about small bio's.
Shorts just look at the understated conclusion and naked short, with their deep pockets. But, science will rule the day and anything under 2 1/2 is a good buy
DTD 9/28/14. The Post doesn't do fluff pieces. They have clout and if enough pressure is put on politicians the worm will turn very quickly. There is no way the naked short position here can be covered without a huge price spike. You can google whole article
The Post article explains how hedge funds can manipulate and actually control the stock prices of small biotechnology companies through short selling strategies. Short sales are done by borrowing shares from another party that owns the shares. These shares can be sold in the market without the seller ever owning them. The short seller must at some time in the future purchase the shares. While short selling is perfectly legal, some short sellers simply don’t bother to borrow the shares. This is naked short selling and it is illegal according to the Washington Post. This can result in overwhelming price pressure on a stock by an unending stream of naked short sells.
Integral to the naked short selling is the operation of dark pools by brokerage firms. It is widely alleged by small biotech companies and their investors that dark pools don’t enforce the requirement for a short seller to deliver borrowed stock within three days of shorting. It is alleged that hedge funds can create an unlimited supply of stock through naked shorting. The compliance officers of the brokerage firm have turned a blind eye to this practice. This could change. The Attorney General of New York is already investigating dark pools for high frequency trading. He can easily expand the investigation to see if they are involved in naked shorting.
The hedge funds use very complex trading strategies that involve trading in dark pools, high frequency trading and sophisticated put and call strategies. They use this technique to walk a stock down. In this technique, a group of hedge funds conspire to systematically take out all bids for stocks for days on end with short selling Less
From the many CC I have listened to and after attending the shareholder meeting, its clear that Ma either doesn't understand the questions in English and his subsequent answers; or he is a liar. There can be no other explanation. The problem for shareholders is that in either case, he is a terrible CEO and a destroyer of our equity.
All medical device makers higher today as device tax might get cut or eliminated with election results. Vaso has said in the past this has cut into "profits." But, as usual no response here.
Earnings date announced today. Ma has promised in SEC documents that we will have actual earnings this Q. Everyone should hold him to it. No more excuses. Ma's pay package should be cut to better align with shareholder returns if he has lied.
What you say, Ma? More of your mumbo jumbo nonsense at CC? Lets hope not.
What is his relationship with the Chinese Government? And Ma? Why did vaso value the company Genwell at 2.1 million. He is part owner and an employee of Vaso. He and his wife also received 190,000 dollars from the original Chinese acquisition.
We bought LET 3 years ago to vertically integrate EECP. But, THERE NEVER has been any demand for eecp. Why would we need to pay for manufacturing end of eecp when there has never been the "increased demand" Ma spoke about at the time of the acquisition. This all looks like Chinese Checkers to shareholders.
Ma needs to be held accountable for wasting all our money on his Chinese buddies.
Mia, must you start your lovers quarrel all over again. Take it somewhere else.
Corked, I am against any Chinese, Black, Hispanic, Indian,or Caucasian CEO who runs a company I OWN into the ground (as defined by share price decline), lies about it, and increases his pay substantially doing same. Now, you may be more forgiving than I, or you may believe in Ma's personal practice of wealth redistribution, or you just may be plain stupid; I don't know. To defend this strategy after 3 years of failure, I think the latter.
But how about this since we will never agree , lets meet at the next shareholder meeting, and you can call me racist and I will call you stupid and we will see what happens.
And, in the interim, why don't you do a little reading on the increasing nationalism in China as it applies to our corporation doing business there. How they steal IP and force our companies to submit to competitive practices well outside of the WTO. That left leaning paper NY Times has many good articles about this which, hopefully, wont offend your progressive sensibilities.
Over 4000 jan 2 calls done today, most bought on the offer at .15. Who is buying and why? This post makes much sense with these call purchases in mind. Big leverage here and much money to be made,,,,,,,follow the money
Haywood said there are two key developments to watch over the next month or so: a potential FDA approval on a medical use for krill oil and changes in the company's leadership.
In addition, HEC agrees to issue to TINA, and TINA agrees to purchase, 6,000,000 Shares at a price of $0.25 per Share. The first 840,000 shares have been purchased and the remainder will be purchased over a period of 6 months. TINA’s President, Pedro Blach, will join VP Bill Ayres and CEO Ted Hollinger on HEC's Board Of Directors.
Is he connected with the Chinese government? Is he related to Ma or anyone else at company? None of the SEC docs give his name; why?
He and vp of BIOX just got almost 2.1 million dollars from us shareholders. They both work for Vaso. Chinese government determined what we shareholders paid. Was this really an arms length transaction? Sounds like a cherry deal for a company whose only assets are patents and IP.
Is this deal accretive also? Maybe in Ma's World it is.
As stock falls Ma should be made to payback some of his piggish 600k compensation package and Castle should be fired.
Ma, how do you justify taking so much from shareholders when they see nothing buy value destruction because of your incompetence.
As usual pj, you deflect and never respond to any details that might shine that positive light that only you seem capable of seeing. I will ask you again, and its a reasonable question; do you think given the underperformance of company shares, that Ma has earned his 600k pay package? Any details will be appreciated.
And while answering that one, you might also address this ; have you earned your pay package?
The statement below is from june 2013 and concerns the new Center set up with millions in donations to study EECP. Vaso was clearly engaged and excited about trials to begin there. So far, no trials have even started. When Ma was asked about the status of the Centers activities during shareholder meeting, he acted like he knew nothing about the goings on there and suggested if shareholders wanted to know anything about it they should call themselves. Does anyone believe that statement? Col Klink could have come up with a better response.
Why does Ma and vaso now disavow any knowledge of this Centers activities when the statement below clearly shows the company's commitment and full participation back in '13. What the hell is Ma doing running a public company? 600k pay package? Are the Chinese (Ma, Li, Hui, Biox VP) selling this once full of potential, American company down the Changjiang.??
At Vasomedical, we have been proponents of EECP Therapy for almost 20 years, seeing incredible benefits to many different patient populations. Stony Brook University was among the first in the United States to adopt EECP Therapy as a noninvasive treatment for cardiac ailments and has participated in many published studies. We are grateful for Stony Brook University and Dr. Poon's continued support and commitment to the research with our innovative devices," said Dr. John Hui, Chief Technology Officer of Vasomedical, Inc. "We look forward to seeing the results of their studies, and are pleased that such a reputable institution is working to raise public awareness and support a technology with the potential to revolutionize the cardiovascular health industry
Get lost raco. You sold out and are about to miss out on nice gains in '15. You got no skin in the game now, just another worthless voyeur, waiting to see a train wreck that never comes.